Praxis Precision Medicines, Inc. (PRAX) stock
PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$305.06−5.21 (-1.68%)
Close on Nov 17, 2026Market cap $8.52BP/E –Yield –
Praxis Precision Medicines operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Praxis Precision Medicines's operating cash flow for the twelve months ending Jun 30, 2026 was -$305.08M. For fiscal 2025 it was -$249.07M. The highest annual figure on record is -$33.42M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$249.07M | – |
| FY2024 | Dec 31, 2024 | -$131.76M | – |
| FY2023 | Dec 31, 2023 | -$111.14M | – |
| FY2022 | Dec 31, 2022 | -$185.04M | – |
| FY2021 | Dec 31, 2021 | -$124.55M | – |
| FY2020 | Dec 31, 2020 | -$52.62M | – |
| FY2019 | Dec 31, 2019 | -$33.42M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$77.54M | – |
| Q1 FY2026 | Mar 31, 2026 | -$86.15M | – |
| Q4 FY2025 | Dec 31, 2025 | -$76.33M | – |
| Q3 FY2025 | Sep 30, 2025 | -$65.06M | – |
| Q2 FY2025 | Jun 30, 2025 | -$54.68M | – |
| Q1 FY2025 | Mar 31, 2025 | -$53.01M | – |
| Q4 FY2024 | Dec 31, 2024 | -$56.12M | – |
| Q3 FY2024 | Sep 30, 2024 | -$27.50M | – |
| Q2 FY2024 | Jun 30, 2024 | -$27.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$20.86M | – |
| Q4 FY2023 | Dec 31, 2023 | -$23.86M | – |
| Q3 FY2023 | Sep 30, 2023 | -$23.22M | – |
| Q2 FY2023 | Jun 30, 2023 | -$31.21M | – |
| Q1 FY2023 | Mar 31, 2023 | -$32.85M | – |
| Q4 FY2022 | Dec 31, 2022 | -$28.81M | – |
| Q3 FY2022 | Sep 30, 2022 | -$44.92M | – |
| Q2 FY2022 | Jun 30, 2022 | -$57.21M | – |
| Q1 FY2022 | Mar 31, 2022 | -$54.11M | – |
| Q4 FY2021 | Dec 31, 2021 | -$44.86M | – |
| Q3 FY2021 | Sep 30, 2021 | -$23.96M | – |
| Q2 FY2021 | Jun 30, 2021 | -$30.01M | – |
| Q1 FY2021 | Mar 31, 2021 | -$25.72M | – |
| Q4 FY2020 | Dec 31, 2020 | -$20.23M | – |
| Q3 FY2020 | Sep 30, 2020 | -$13.88M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.94M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.57M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.95M | – |
See a number that looks wrong?